Alpha Cognition (ACOG) Long-Term Deferred Tax (2025)

Alpha Cognition's (ACOG) quarterly Long-Term Deferred Tax came in at $11.0 million in Q4 2025.

Alpha Cognition (ACOG) Long-Term Deferred Tax (2025) Analysis & Trends

Alpha Cognition's Long-Term Deferred Tax history runs 1 years deep, the most recent figure standing at $11.0 million for Q4 2025.

On a quarterly basis, Long-Term Deferred Tax changed N/A year-over-year to $11.0 million in Q4 2025; TTM through Dec 2025 was $11.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $11.0 million, changed N/A from the prior year.
Long-Term Deferred Tax steadied at $11.0 million in Q4 2025 per ACOG's latest filing.
Across five years, Long-Term Deferred Tax topped out at $11.0 million in Q4 2025 and bottomed at $11.0 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Alpha Cognition	145.51 Mn	79.41 Mn	2.61 Mn

Download Data

Date	Value
Dec 31, 2025	11.00 Mn